This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1978 Aug 26;2(6137):602.

doi: 10.1136/bmj.2.6137.602.

Interstitial lung disease in a patient treated with 5-fluorouracil and mitomycin C

J W Fielding, R A Stockley, V S Brookes

PMID: 698608
PMCID: PMC1607549
DOI: 10.1136/bmj.2.6137.602

Case Reports

Interstitial lung disease in a patient treated with 5-fluorouracil and mitomycin C

J W Fielding et al. Br Med J. 1978.

. 1978 Aug 26;2(6137):602.

doi: 10.1136/bmj.2.6137.602.

Authors

J W Fielding, R A Stockley, V S Brookes

PMID: 698608
PMCID: PMC1607549
DOI: 10.1136/bmj.2.6137.602

No abstract available

PubMed Disclaimer

Similar articles

Interstitial fibrosis in a patient treated with 5-fluorouracil and mitomycin C.
Fielding JW, Crocker J, Stockley RA, Brookes VS. Fielding JW, et al. Br Med J. 1979 Sep 1;2(6189):551-2. doi: 10.1136/bmj.2.6189.551-b. Br Med J. 1979. PMID: 497693 Free PMC article. No abstract available.
Two patients suffering from interstitial pneumonitis and haemolytic-uraemic syndrome as side effects of mitomycin C therapy.
van Spreeuwel JP, Hemrika MH, de Maat CE, Nadorp JH. van Spreeuwel JP, et al. Neth J Med. 1983;26(9):287-8. Neth J Med. 1983. PMID: 6419134 No abstract available.
Mitomycin and interstitial pneumonitis.
Andrews AT, Bowman HS, Patel SB, Anderson WM. Andrews AT, et al. Ann Intern Med. 1979 Jan;90(1):127. doi: 10.7326/0003-4819-90-1-127_1. Ann Intern Med. 1979. PMID: 420448 No abstract available.
Prospective study on the dose relationship of mitomycin C-induced interstitial pneumonitis.
Verweij J, van Zanten T, Souren T, Golding R, Pinedo HM. Verweij J, et al. Cancer. 1987 Aug 15;60(4):756-61. doi: 10.1002/1097-0142(19870815)60:4<756::aid-cncr2820600408>3.0.co;2-h. Cancer. 1987. PMID: 3109726 Review.
Pulmonary effects of cytotoxic agents other than bleomycin.
Twohig KJ, Matthay RA. Twohig KJ, et al. Clin Chest Med. 1990 Mar;11(1):31-54. Clin Chest Med. 1990. PMID: 1691069 Review.

See all similar articles

Cited by

Interstitial lung disease secondary to Cetuximab in bladder cancer: an Oncologist's perspective.
Price L, Glynn P, Zarkar A. Price L, et al. BMJ Case Rep. 2017 Dec 20;2017:bcr2017220181. doi: 10.1136/bcr-2017-220181. BMJ Case Rep. 2017. PMID: 29269357 Free PMC article.
Experimental bleomycin lung in mice. A contribution to the pathogenesis of pulmonary fibrosis.
Fasske E, Morgenroth K. Fasske E, et al. Lung. 1983;161(3):133-46. doi: 10.1007/BF02713855. Lung. 1983. PMID: 6192292 No abstract available.
Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
Crocker J, Jones EL. Crocker J, et al. J Clin Pathol. 1983 Jan;36(1):24-9. doi: 10.1136/jcp.36.1.24. J Clin Pathol. 1983. PMID: 6401771 Free PMC article.
Lung damage from cytotoxic drugs.
Collis CH. Collis CH. Cancer Chemother Pharmacol. 1980;4(1):17-27. doi: 10.1007/BF00255453. Cancer Chemother Pharmacol. 1980. PMID: 6153937 Review.

References

1. J Appl Physiol. 1963 Mar;18:284-8 - PubMed
1. Am J Med. 1977 Apr;62(4):608-15 - PubMed
1. Cancer. 1973 Apr;31(4):903-14 - PubMed
1. Can Med Assoc J. 1973 Mar 17;108(6):710-4 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central